
### [MONDO:0019690](http://purl.obolibrary.org/obo/MONDO_0019690)
**Label:** filamin-related bone disorder

**Subclasses:** [MONDO:0010094](http://purl.obolibrary.org/obo/MONDO_0010094) (spondylocarpotarsal synostosis syndrome), [MONDO:0019027](http://purl.obolibrary.org/obo/MONDO_0019027) (otopalatodigital syndrome), [MONDO:0010650](http://purl.obolibrary.org/obo/MONDO_0010650) (Melnick-Needles syndrome), [MONDO:0018233](http://purl.obolibrary.org/obo/MONDO_0018233) (Otopalatodigital syndrome spectrum disorder), [MONDO:0010571](http://purl.obolibrary.org/obo/MONDO_0010571) (Otopalatodigital syndrome type 2), [MONDO:0009579](http://purl.obolibrary.org/obo/MONDO_0009579) (Frank-Ter Haar syndrome), [MONDO:0007208](http://purl.obolibrary.org/obo/MONDO_0007208) (Boomerang dysplasia), [MONDO:0007875](http://purl.obolibrary.org/obo/MONDO_0007875) (larsen syndrome), [MONDO:0010704](http://purl.obolibrary.org/obo/MONDO_0010704) (Otopalatodigital syndrome type 1), [MONDO:0007168](http://purl.obolibrary.org/obo/MONDO_0007168) (atelosteogenesis type III), [MONDO:0007167](http://purl.obolibrary.org/obo/MONDO_0007167) (atelosteogenesis type i), [MONDO:0010279](http://purl.obolibrary.org/obo/MONDO_0010279) (terminal osseous dysplasia-pigmentary defects syndrome), [MONDO:0014935](http://purl.obolibrary.org/obo/MONDO_0014935) (Frontometaphyseal dysplasia 2; FMD2), [MONDO:0015942](http://purl.obolibrary.org/obo/MONDO_0015942) (frontometaphyseal dysplasia), 

**Mapped go classes:** [GO:0014069](http://purl.obolibrary.org/obo/GO_0014069) (postsynaptic density), [GO:0007252](http://purl.obolibrary.org/obo/GO_0007252) (I-kappaB phosphorylation), [GO:1904179](http://purl.obolibrary.org/obo/GO_1904179) (positive regulation of adipose tissue development), [GO:0007179](http://purl.obolibrary.org/obo/GO_0007179) (transforming growth factor beta receptor signaling pathway), [GO:0045600](http://purl.obolibrary.org/obo/GO_0045600) (positive regulation of fat cell differentiation), [GO:0048514](http://purl.obolibrary.org/obo/GO_0048514) (blood vessel morphogenesis), [GO:0000186](http://purl.obolibrary.org/obo/GO_0000186) (activation of MAPKK activity), [GO:0001501](http://purl.obolibrary.org/obo/GO_0001501) (skeletal system development), [GO:0006915](http://purl.obolibrary.org/obo/GO_0006915) (apoptotic process), [GO:0016175](http://purl.obolibrary.org/obo/GO_0016175) (superoxide-generating NADPH oxidase activity), [GO:0016176](http://purl.obolibrary.org/obo/GO_0016176) (superoxide-generating NADPH oxidase activator activity), [GO:0016239](http://purl.obolibrary.org/obo/GO_0016239) (positive regulation of macroautophagy), [GO:1902443](http://purl.obolibrary.org/obo/GO_1902443) (negative regulation of ripoptosome assembly involved in necroptotic process), [GO:0002051](http://purl.obolibrary.org/obo/GO_0002051) (osteoblast fate commitment), [GO:0080025](http://purl.obolibrary.org/obo/GO_0080025) (phosphatidylinositol-3,5-bisphosphate binding), [GO:0043276](http://purl.obolibrary.org/obo/GO_0043276) (anoikis), [GO:0004672](http://purl.obolibrary.org/obo/GO_0004672) (protein kinase activity), [GO:0004674](http://purl.obolibrary.org/obo/GO_0004674) (protein serine/threonine kinase activity), [GO:0005886](http://purl.obolibrary.org/obo/GO_0005886) (plasma membrane), [GO:0051015](http://purl.obolibrary.org/obo/GO_0051015) (actin filament binding), [GO:0070273](http://purl.obolibrary.org/obo/GO_0070273) (phosphatidylinositol-4-phosphate binding), [GO:0006801](http://purl.obolibrary.org/obo/GO_0006801) (superoxide metabolic process), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0003779](http://purl.obolibrary.org/obo/GO_0003779) (actin binding), [GO:0051496](http://purl.obolibrary.org/obo/GO_0051496) (positive regulation of stress fiber assembly), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0010628](http://purl.obolibrary.org/obo/GO_0010628) (positive regulation of gene expression), [GO:0072657](http://purl.obolibrary.org/obo/GO_0072657) (protein localization to membrane), [GO:0004708](http://purl.obolibrary.org/obo/GO_0004708) (MAP kinase kinase activity), [GO:0030054](http://purl.obolibrary.org/obo/GO_0030054) (cell junction), [GO:0004709](http://purl.obolibrary.org/obo/GO_0004709) (MAP kinase kinase kinase activity), [GO:0071800](http://purl.obolibrary.org/obo/GO_0071800) (podosome assembly), [GO:0043123](http://purl.obolibrary.org/obo/GO_0043123) (positive regulation of I-kappaB kinase/NF-kappaB signaling), [GO:0006468](http://purl.obolibrary.org/obo/GO_0006468) (protein phosphorylation), [GO:0042995](http://purl.obolibrary.org/obo/GO_0042995) (cell projection), [GO:0040018](http://purl.obolibrary.org/obo/GO_0040018) (positive regulation of multicellular organism growth), [GO:0002102](http://purl.obolibrary.org/obo/GO_0002102) (podosome), [GO:0060348](http://purl.obolibrary.org/obo/GO_0060348) (bone development), [GO:0060546](http://purl.obolibrary.org/obo/GO_0060546) (negative regulation of necroptotic process), [GO:0000287](http://purl.obolibrary.org/obo/GO_0000287) (magnesium ion binding), [GO:0000166](http://purl.obolibrary.org/obo/GO_0000166) (nucleotide binding), [GO:0007507](http://purl.obolibrary.org/obo/GO_0007507) (heart development), [GO:0005524](http://purl.obolibrary.org/obo/GO_0005524) (ATP binding), [GO:0000165](http://purl.obolibrary.org/obo/GO_0000165) (MAPK cascade), [GO:0001841](http://purl.obolibrary.org/obo/GO_0001841) (neural tube formation), [GO:0001525](http://purl.obolibrary.org/obo/GO_0001525) (angiogenesis), [GO:0010314](http://purl.obolibrary.org/obo/GO_0010314) (phosphatidylinositol-5-phosphate binding), [GO:2000377](http://purl.obolibrary.org/obo/GO_2000377) (regulation of reactive oxygen species metabolic process), [GO:0032266](http://purl.obolibrary.org/obo/GO_0032266) (phosphatidylinositol-3-phosphate binding), [GO:0016310](http://purl.obolibrary.org/obo/GO_0016310) (phosphorylation), [GO:2000378](http://purl.obolibrary.org/obo/GO_2000378) (negative regulation of reactive oxygen species metabolic process), [GO:0007165](http://purl.obolibrary.org/obo/GO_0007165) (signal transduction), [GO:0006351](http://purl.obolibrary.org/obo/GO_0006351) (transcription, DNA-templated), [GO:0022617](http://purl.obolibrary.org/obo/GO_0022617) (extracellular matrix disassembly), [GO:0035091](http://purl.obolibrary.org/obo/GO_0035091) (phosphatidylinositol binding), [GO:1904888](http://purl.obolibrary.org/obo/GO_1904888) (cranial skeletal system development), [GO:0006355](http://purl.obolibrary.org/obo/GO_0006355) (regulation of transcription, DNA-templated), [GO:0042169](http://purl.obolibrary.org/obo/GO_0042169) (SH2 domain binding), [GO:0060378](http://purl.obolibrary.org/obo/GO_0060378) (regulation of brood size), [GO:0048705](http://purl.obolibrary.org/obo/GO_0048705) (skeletal system morphogenesis), [GO:0005622](http://purl.obolibrary.org/obo/GO_0005622) (intracellular), [GO:0060612](http://purl.obolibrary.org/obo/GO_0060612) (adipose tissue development), [GO:0097110](http://purl.obolibrary.org/obo/GO_0097110) (scaffold protein binding), [GO:0001654](http://purl.obolibrary.org/obo/GO_0001654) (eye development), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0046330](http://purl.obolibrary.org/obo/GO_0046330) (positive regulation of JNK cascade), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0030154](http://purl.obolibrary.org/obo/GO_0030154) (cell differentiation), [GO:0055114](http://purl.obolibrary.org/obo/GO_0055114) (oxidation-reduction process), [GO:0016740](http://purl.obolibrary.org/obo/GO_0016740) (transferase activity), [GO:0030036](http://purl.obolibrary.org/obo/GO_0030036) (actin cytoskeleton organization), [GO:0016301](http://purl.obolibrary.org/obo/GO_0016301) (kinase activity), [GO:2001234](http://purl.obolibrary.org/obo/GO_2001234) (negative regulation of apoptotic signaling pathway), 

**Class expressions from DL-Learner:**

- Thing 53.13%
- [GO:0080025](http://purl.obolibrary.org/obo/GO_0080025) (phosphatidylinositol-3,5-bisphosphate binding) 52.08%
- [GO:0070273](http://purl.obolibrary.org/obo/GO_0070273) (phosphatidylinositol-4-phosphate binding) 52.08%
- [GO:0032266](http://purl.obolibrary.org/obo/GO_0032266) (phosphatidylinositol-3-phosphate binding) 52.08%
- [GO:0016176](http://purl.obolibrary.org/obo/GO_0016176) (superoxide-generating NADPH oxidase activator activity) 52.08%
- [GO:0010314](http://purl.obolibrary.org/obo/GO_0010314) (phosphatidylinositol-5-phosphate binding) 52.08%
- [GO:1901981](http://purl.obolibrary.org/obo/GO_1901981) (phosphatidylinositol phosphate binding) 46.13%
- [GO:1901981](http://purl.obolibrary.org/obo/GO_1901981) (phosphatidylinositol phosphate binding) and ([GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function) or [GO:2001221](http://purl.obolibrary.org/obo/GO_2001221) (obsolete positive regulation of G2 phase of mitotic cell cycle)) 46.13%
- [GO:1901981](http://purl.obolibrary.org/obo/GO_1901981) (phosphatidylinositol phosphate binding) and ([GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function) or [GO:2001220](http://purl.obolibrary.org/obo/GO_2001220) (obsolete negative regulation of G2 phase of mitotic cell cycle)) 46.13%
- [GO:1901981](http://purl.obolibrary.org/obo/GO_1901981) (phosphatidylinositol phosphate binding) and ([GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function) or [GO:2001219](http://purl.obolibrary.org/obo/GO_2001219) (obsolete positive regulation of S/G2 transition of mitotic cell cycle)) 46.13%
- [GO:1901981](http://purl.obolibrary.org/obo/GO_1901981) (phosphatidylinositol phosphate binding) and ([GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function) or [GO:2001218](http://purl.obolibrary.org/obo/GO_2001218) (obsolete negative regulation of S/G2 transition of mitotic cell cycle)) 46.13%
- [GO:1901981](http://purl.obolibrary.org/obo/GO_1901981) (phosphatidylinositol phosphate binding) and ([GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function) or [GO:2001217](http://purl.obolibrary.org/obo/GO_2001217) (obsolete regulation of S/G2 transition of mitotic cell cycle)) 46.13%
- [GO:1901981](http://purl.obolibrary.org/obo/GO_1901981) (phosphatidylinositol phosphate binding) and ([GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function) or [GO:2001052](http://purl.obolibrary.org/obo/GO_2001052) (null)) 46.13%
- [GO:1901981](http://purl.obolibrary.org/obo/GO_1901981) (phosphatidylinositol phosphate binding) and ([GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function) or [GO:2001048](http://purl.obolibrary.org/obo/GO_2001048) (null)) 46.13%
- [GO:1901981](http://purl.obolibrary.org/obo/GO_1901981) (phosphatidylinositol phosphate binding) and ([GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function) or [GO:2001047](http://purl.obolibrary.org/obo/GO_2001047) (null)) 46.13%


